Introduction
The common complex disorders have a polygenic genetic structure, which enables researchers to identify variants associated with diseases. The gene variants can be combined with polygenic risk scores to find susceptible individuals to the disease. Polygenic risk scores can be used to establish the right choice of treatment by diagnosing the risk of the disease prior. It can estimate an individual’s lifetime risk of genetic disease, but its clinical use is yet to be established. Genome-wide association studies (GWAS) have contributed to research on inherited variants of the complex disorder. According to a current study, the most communicable disorder has thousands of genetic variants (polymorphisms). Each genetic variant has a small effect on disease risk. The pathway or the biological relevance to the disorder is revealed by each genetic variant associated with the disease. The genetic data of the disease is used to predict the disease risk. This article explains polygenic risk scores.
What Is Polygenic Risk Score?
Polygenic disorder is a disease that has multiple genetic causes. Polygenic risk score (PRS) refers to a weighted average of the risk alleles that a person carries. Polygenic risk scores may be useful at different points in the disease diagnosis, from healthy people who are being screened for future disease risk to people who have already been diagnosed, determining how genetic information might influence their course of treatment. It may provide prognostic information prior to disease. According to GWAS, a polygenic risk score is formed from a set of genetic variants. Each variant's risk alleles (0, 1, or 2) are added up, and their effect sizes on each person are weighted. The result is a single score that represents each person's genetic loading for a condition or a continuous trait.
The following are the properties of polygenic risk score;-
-
Polygenic risk score depicts the genetic architecture of common complex illnesses can determine it, where minimal evidence of genetic variation interactions is found.
-
There are no gene-gene or gene-environment interactions modeled by polygenic risk scores.
How Is Polygenic Risk Score Calculated?
-
The information that is now available demonstrates where one stands on the risk spectrum in relation to others.
-
The possibility of inaccurate data, for instance, where the person differs from the characteristics of the research study used to calculate the magnitude of each genetic variation's impact on each of the following factors: age, environmental load, disease classification, or locations where there is a bias in the way the data were collected.
-
When employing the PRS to drive behavior change as opposed to a pharmaceutical intervention, for instance, more detailed information would be needed to support the pharmacological intervention.
What Is the Advantage of a Polygenic Risk Score?
Polygenic risk scores (PRS) are a statistical method used in genetics to estimate an individual's genetic risk for a particular trait or disease. They are calculated by combining information from multiple genetic variants across the genome that have been associated with the trait or disease in question. Polygenic risk scores have several advantages:
-
Predictive Power: Polygenic risk scores can provide a more accurate prediction of an individual's risk for developing a certain trait or disease compared to traditional single-gene approaches. By considering a large number of genetic variants, PRS can capture the cumulative effect of multiple genetic factors, which often contribute in a complex and combined manner to the trait or disease.
-
Early Risk Identification: PRS can be calculated using genetic data obtained early in life, even before the onset of symptoms or disease development. This early identification of individuals at higher risk can enable preventive measures, lifestyle modifications, or targeted interventions to reduce the likelihood or severity of disease.
-
Personalized Medicine: Polygenic risk scores can help in tailoring medical interventions and treatments based on an individual's genetic risk. They can assist in stratifying patients into high-risk and low-risk groups, allowing for personalized medical decisions, such as determining screening frequency, selecting appropriate interventions, or guiding medication choices.
-
Research and Drug Development: Polygenic risk scores have the potential to advance scientific research and drug development by identifying specific genetic factors associated with disease risk. By focusing on these genetic variants, researchers can learn about the biological processes that underlie the disease, develop new therapeutic targets, and test the efficacy of treatments in individuals with high genetic risk.
-
Public Health Applications: PRS can have implications for public health initiatives by identifying populations at higher risk for certain diseases. This information can be used to guide public health policies, implement targeted screening programs, and allocate resources more efficiently to reduce the burden of disease on a societal level.
Conclusion
Polygenic risk scores can have clinical implications. It can be used for prior diagnosis and treatment. The therapeutic applicability of polygenic scores has not yet been established despite the growing body of research studies that demonstrate a highly substantial correlation between polygenic scores and illness status.
